SG10201900006XA - Oxygen-enriched water composition, biocompatible composition comprising the same, and methods of preparing and using the same - Google Patents

Oxygen-enriched water composition, biocompatible composition comprising the same, and methods of preparing and using the same

Info

Publication number
SG10201900006XA
SG10201900006XA SG10201900006XA SG10201900006XA SG10201900006XA SG 10201900006X A SG10201900006X A SG 10201900006XA SG 10201900006X A SG10201900006X A SG 10201900006XA SG 10201900006X A SG10201900006X A SG 10201900006XA SG 10201900006X A SG10201900006X A SG 10201900006XA
Authority
SG
Singapore
Prior art keywords
oxygen
same
enriched water
composition
water composition
Prior art date
Application number
SG10201900006XA
Inventor
Tang Ming Wu
Original Assignee
Oxy Young Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from TW104127596A external-priority patent/TWI529139B/en
Priority claimed from TW104128012A external-priority patent/TWI573593B/en
Application filed by Oxy Young Co Ltd filed Critical Oxy Young Co Ltd
Publication of SG10201900006XA publication Critical patent/SG10201900006XA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A23L2/54—Mixing with gases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F1/00—Treatment of water, waste water, or sewage
    • C02F1/68—Treatment of water, waste water, or sewage by addition of specified substances, e.g. trace elements, for ameliorating potable water
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F1/00—Treatment of water, waste water, or sewage
    • C02F1/72—Treatment of water, waste water, or sewage by oxidation
    • C02F1/727—Treatment of water, waste water, or sewage by oxidation using pure oxygen or oxygen rich gas
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F2103/00—Nature of the water, waste water, sewage or sludge to be treated
    • C02F2103/02—Non-contaminated water, e.g. for industrial water supply
    • C02F2103/026—Treating water for medical or cosmetic purposes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Hydrology & Water Resources (AREA)
  • Environmental & Geological Engineering (AREA)
  • Water Supply & Treatment (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

OXYGENENRICHED WATER COMPOSITION, BIOCOMPATIBLE COMPOSITION COMPRISING THE SAME, AND METHODS OF PREPARING AND USING THE SAME Provided is use of an oxygen-enriched water composition comprising water and oxygen in the manufacture of a medicament for treatment and/or prevention of hyperuricemia, wherein: (a) the oxygen-enriched water composition comprises an oxygen content of no less than ppm when the oxygen content of the oxygen-enriched water composition is measured at a temperature ranging from 4 C to 50 C; and (b) the oxygen content of the oxygen-enriched water composition has a ° ° temporal stability and a temperature stability characterized by the following features: provided that the oxygen content measured at a given time point t o is 100%, the oxygen content measured at 30 minutes from the given time point to is A%, and the oxygen content measured at 180 minutes from the given time point t o is B%, then a difference between A% and B% is less than 24%; and the oxygen content is maintained at no less than 20 ppm when the oxygen-enriched water composition is placed under a temperature ranging from 30 °C to 40 °C for at least 60 minutes. 42
SG10201900006XA 2015-08-25 2016-08-08 Oxygen-enriched water composition, biocompatible composition comprising the same, and methods of preparing and using the same SG10201900006XA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TW104127596A TWI529139B (en) 2015-08-25 2015-08-25 High oxygen water, biocompatible composition containing high oxygen water and preparation method of high oxygen water
TW104128012A TWI573593B (en) 2015-08-26 2015-08-26 High oxygen water in the manufacture of a medicament for the treatment and / or prevention of hyperuricemia

Publications (1)

Publication Number Publication Date
SG10201900006XA true SG10201900006XA (en) 2019-02-27

Family

ID=56683736

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201606557RA SG10201606557RA (en) 2015-08-25 2016-08-08 Oxygen-enriched water composition, biocompatible composition comprising the same, and methods of preparing and using the same
SG10201900006XA SG10201900006XA (en) 2015-08-25 2016-08-08 Oxygen-enriched water composition, biocompatible composition comprising the same, and methods of preparing and using the same

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG10201606557RA SG10201606557RA (en) 2015-08-25 2016-08-08 Oxygen-enriched water composition, biocompatible composition comprising the same, and methods of preparing and using the same

Country Status (10)

Country Link
US (1) US20170056439A1 (en)
EP (1) EP3135120A1 (en)
JP (1) JP2017043602A (en)
KR (1) KR20170024537A (en)
AU (1) AU2016208449A1 (en)
CA (1) CA2937729A1 (en)
NZ (1) NZ730267A (en)
PH (1) PH12016000285A1 (en)
RU (1) RU2016133355A (en)
SG (2) SG10201606557RA (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11881201B2 (en) 2019-09-03 2024-01-23 Sony Group Corporation Control apparatus, loudspeaker apparatus, and audio output method
US20230007434A1 (en) 2019-12-19 2023-01-05 Sony Group Corporation Control apparatus, signal processing method, and speaker apparatus

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU217450B (en) * 1994-04-27 2000-01-28 Life International Products, Inc. Process and apparatus for producing beverage rich in oxigen
US6913382B2 (en) * 2000-04-27 2005-07-05 Denis-Michel Ledoux Treatment of fluids
JP4080440B2 (en) * 2004-03-05 2008-04-23 独立行政法人産業技術総合研究所 Oxygen nanobubble water and method for producing the same
JP2006043681A (en) * 2004-06-30 2006-02-16 Seiwa Pro:Kk Functional water, and method and apparatus for producing the same
US20060273043A1 (en) * 2005-06-03 2006-12-07 BAGLEY David Method for producing super-oxygenated and structured water
CA2667791A1 (en) * 2006-10-25 2008-05-02 Revalesio Corporation Methods of therapeutic treatment of eyes and other human tissues using an oxygen-enriched solution
JP5207430B2 (en) * 2006-10-30 2013-06-12 独立行政法人産業技術総合研究所 NOVEL ENZYME AND COMPOSITION CONTAINING THE SAME
JP5591118B2 (en) * 2007-12-14 2014-09-17 ビーエーエスエフ ソシエタス・ヨーロピア Method for producing water-absorbing polymer particles
FR2925480B1 (en) * 2007-12-21 2011-07-01 Gervais Danone Sa PROCESS FOR THE ENRICHMENT OF OXYGEN WATER BY ELECTROLYTIC, OXYGEN-ENRICHED WATER OR DRINK AND USES THEREOF
BR112012028540A2 (en) * 2010-05-07 2016-07-26 Revalesio Corp compositions and methods for improving physiological performance and recovery time
JP2014014357A (en) * 2012-06-14 2014-01-30 Takaaki Matsumoto Beverage for improving liver function and renal function, and method for manufacturing the same
CN202705029U (en) 2012-06-19 2013-01-30 禾氧生技股份有限公司 Oxygen manufacturing machine
CN202820947U (en) 2012-06-20 2013-03-27 禾氧生技股份有限公司 High dissolved oxygen content water dispenser
CN202932748U (en) 2012-10-22 2013-05-15 禾氧生技股份有限公司 Small-molecule high-oxygen water dispenser
JP5948259B2 (en) * 2013-01-24 2016-07-06 日本電信電話株式会社 Sound collection device and playback device
CN104045121A (en) * 2013-03-15 2014-09-17 常州金赛肿瘤医药科技有限公司 Preparation and application methods of micromolecular water

Also Published As

Publication number Publication date
US20170056439A1 (en) 2017-03-02
JP2017043602A (en) 2017-03-02
KR20170024537A (en) 2017-03-07
NZ730267A (en) 2017-10-27
NZ722757A (en) 2017-04-28
PH12016000285A1 (en) 2018-02-19
AU2016208449A1 (en) 2017-03-16
SG10201606557RA (en) 2017-03-30
EP3135120A1 (en) 2017-03-01
CA2937729A1 (en) 2017-02-25
RU2016133355A (en) 2018-02-16

Similar Documents

Publication Publication Date Title
PH12020500352A1 (en) Therapeutic uses of empagliflozin
IN2015DN01156A (en)
NZ733174A (en) Quinazoline derivatives used to treat hiv
MX2016011700A (en) Surface-reacted calcium carbonate for desensitizing teeth.
MX2020013740A (en) Therapeutic uses of empagliflozin.
NZ727304A (en) Compositions and methods of use of phorbol esters for the treatment of stroke
MY192055A (en) Compounds and compositions for the treatment or prevention of pathological conditions associated with excess fibrin deposition and/or thrombus formation
EA201790726A1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ULCERAL COLITIS
MX2015011359A (en) Macrocyclic lrrk2 kinase inhibitors.
SG10201811078XA (en) Method Of Treatment Of Hypoxia Inducible Factor (HIF)-Related Conditions
PH12017500563A1 (en) Stabilized adrenomedullin derivatives and use thereof
UA118474C2 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
PH12019501439A1 (en) Use of lactic acid bacteria to treat or prevent gestational diabetes mellitus
SG10201900006XA (en) Oxygen-enriched water composition, biocompatible composition comprising the same, and methods of preparing and using the same
MX2021001228A (en) Composition for use in the prevention and/or treatment of the genitourinary mucosa.
SG10201809673RA (en) Treatment of androgen deprivation therapy associated symptoms
MY186523A (en) Macrocyclic rip2 kinase inhibitors
MX2023005014A (en) Methods of treating chronic inflammatory diseases.
PH12017501918A1 (en) Multi-peptide composition
PH12016502107A1 (en) Combination of brexpiprazole and nalmefene and use thereof for treating substance-related disorders
MY197404A (en) Benzoic acid or a salt and derivative thereof for use in preventing or treating depression
EP4335460A3 (en) Compositions and methods for treating granulomatosis with polyangiitis
WO2018132160A3 (en) Methods of treating or preventing type 1 diabetes
MX2018001318A (en) Transdermal delivery system.
IN2013MU01248A (en)